Brief: Vicore Reports Data From Endopat Exploratory Trial
Aug 22 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* VICORE REPORTS DATA FROM ENDOPAT® EXPLORATORY TRIAL
* DATA FROM ENDOPAT® EXPLORATORY TRIAL WERE INCONCLUSIVE
* INTRA-INDIVIDUAL VARIABILITY IN ENDOPAT® ASSESSMENTS WAS
HIGH,
INCLUDING BETWEEN PLACEBO AND BASELINE READINGS IN PRIMARY
MEASURE, REACTIVE HYPEREMIA INDEX SCORE, RESULTING IN
INCONCLUSIVE DATA
Source text for Eikon: ID:nMFN482lrX
Further company coverage: VICOR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2